SEARCH RESULTS FOR:

Mining
Guinea
Cote d’Ivoire
Mali
Senegal
Burkina Faso
Niger
Benin
Togo
MACIG

MACIG 2019 West Africa Pre-Release Edition

Mining
South Africa
MACIG

Edwin Ludick

MANAGING DIRECTOR, AEL INTELLIGENT BLASTING
MACIG 2019 Pre-Release
AEL Intelligent Blasting explains to GBR how it is developing intelligent solutions for blasting across Africa and beyond.
Mining
Peru

The Role of Women in Peru’s Mining Industry

by Lita Calenzani, President, Women in Mining Peru (WiM Peru)
Mining
Canada

Alicia Woods

GENERAL MANAGER, MARCOTTE MINING
Ontario Mining 2018 Pre-Release Edition
GBR speaks with Marcotte Mining about how technology and innovation must drive the business.
Mining
DRC
MACIG

Justine Stubbs

GROUP GENERAL MANAGER, AXIS HOUSE
MACIG 2019 Pre-Release
Axis House provides chemicals and advise to mining companies across Africa and speaks with GBR in DRC.
Mining
DRC
MACIG

Anaiah Bewa

EXECUTIVE HEAD OF CORPORATE AFFAIRS, VODACOM CONGO
MACIG 2019 Pre-Release
Vodacom Congl explains to GBR how the mobile telecommunications services can be tailored to best benefit mine sites in remote locations.
Mining
Peru

Alexandra Almenara

GENERAL MANAGER, SNC-LAVALIN PERU
SNC-Lavalin is enjoying a swift recovery in Peru and elsewhere and is further developing its offering.
Mining
Canada

Mining 2.0: Sustainable Cash Flows Has New Meaning

Dean McPherson defines ‘Mining 2.0’, a new era driven by responsible and innovation-driven mining.
Mexico
Petrochemicals & Chemicals

José M. Berges

CEO, GTM
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
GTM has experienced rapid expansion in recent years and speaks to GBR about its Latin American businesses.
Mining
Australia
Ghana
MACIG

Vincent Mascolo

CEO, IRONRIDGE RESOURCES
MACIG 2019 Pre-Release
IronRidge explains its Afrocentric focus.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL